title: Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
abstract: BACKGROUND
  Renal transplantation is associated with an increased incidence of nonmela-noma skin cancer (NMSC) caused by immunosuppression. Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), the two major histological types of NMSC, exhibit more aggressive biological and clinical courses in renal transplant recipients (RTRs), with higher rates of recurrence and mortality than in the general population.
  
  
  METHODS
  We retrospectively analyzed our experience of NMSC in 1736 renal transplantations performed over a 25-year period. All cases of skin cancer after renal transplantation were included except those of skin cancer resulting from melanoma and mesenchymal skin tumors.
  
  
  RESULTS
  In our series, the overall incidence of NMSC after transplantation was 2.2% (n = 39), and SCC represented the most frequent skin malignancy (64.1%), followed by BCC (17.9%), Bowen's disease (10.2%), basosquamous carcinoma (5.1%), and a rare case of invasive sebaceous carcinoma (2.6%). A shift to newer immunosuppressive regimens after the initial diagnosis of NMSC had been implemented in eight cases (20.5%). The recurrence rate after initial treatment was 41% (n = 16), and distant metastatic disease was diagnosed in 15.4% (n = 6) of NMSC patients. The NMSC-specific mortality rate was 25.6% (n = 10).
  
  
  CONCLUSIONS
  Nonmelanoma skin cancer remains a significant source of morbidity and mortality in RTRs, and post-transplant surveillance should be increased.
authors.affiliation: Transplantation Unit, Laiko General Hospital, Athens, Greece.
authors.forename: George
authors.initials: G
authors.lastname: Zavos
authors.forename: Nikolaos P
authors.initials: NP
authors.lastname: Karidis
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Tsourouflis
authors.forename: John
authors.initials: J
authors.lastname: Bokos
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Diles
authors.forename: George
authors.initials: G
authors.lastname: Sotirchos
authors.forename: Eleni
authors.initials: E
authors.lastname: Theodoropoulou
authors.forename: Alkiviadis
authors.initials: A
authors.lastname: Kostakis
mesh_terms: D018266:Adenocarcinoma, Sebaceous / Q000453:epidemiology / Q000209:etiology; D000328:Adult; D000368:Aged; D002280:Basal Cell Carcinoma / Q000453:epidemiology / Q000209:etiology*; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000209:etiology; D012189:Retrospective Studies; D012626:Sebaceous Gland Neoplasms / Q000453:epidemiology / Q000209:etiology; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology*; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents